T1	Participants 84 128	acutely decompensated chronic heart failure.
T2	Participants 244 322	patients with decompensated heart failure (HF), but without survival benefits.
T3	Participants 557 592	Sixty-nine patients were randomized
T4	Participants 2046 2062	decompensated HF
